What Happened?
Cambridge, -based Axcella-Health Promoted Paul Fehlner as Senior Vice President, Chief Legal Officer and Corporate Secretary
About the Company
Axcella is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella`s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella`s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.
About the Person
Paul Fehlner is Senior Vice President, Chief Legal Officer and Corporate Secretary at Axcella Health. Previously, Paul held various senior legal leadership roles in the industry.
Info Source
News
Short Profile